ZA200704869B - Therapeutic compositions for intranasal administration of ketorolac - Google Patents

Therapeutic compositions for intranasal administration of ketorolac

Info

Publication number
ZA200704869B
ZA200704869B ZA200704869A ZA200704869A ZA200704869B ZA 200704869 B ZA200704869 B ZA 200704869B ZA 200704869 A ZA200704869 A ZA 200704869A ZA 200704869 A ZA200704869 A ZA 200704869A ZA 200704869 B ZA200704869 B ZA 200704869B
Authority
ZA
South Africa
Prior art keywords
ketorolac
therapeutic compositions
intranasal administration
intranasal
administration
Prior art date
Application number
ZA200704869A
Other languages
English (en)
Inventor
Whiting Roger
Thirucote Ramachandran
Original Assignee
Roxro Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roxro Pharma Inc filed Critical Roxro Pharma Inc
Publication of ZA200704869B publication Critical patent/ZA200704869B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200704869A 2004-12-23 2005-12-15 Therapeutic compositions for intranasal administration of ketorolac ZA200704869B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63902204P 2004-12-23 2004-12-23

Publications (1)

Publication Number Publication Date
ZA200704869B true ZA200704869B (en) 2009-02-25

Family

ID=36390269

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200704869A ZA200704869B (en) 2004-12-23 2005-12-15 Therapeutic compositions for intranasal administration of ketorolac
ZA200806671A ZA200806671B (en) 2004-12-23 2008-07-31 Therapeutic compositions for intranasal administration of ketorolac

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200806671A ZA200806671B (en) 2004-12-23 2008-07-31 Therapeutic compositions for intranasal administration of ketorolac

Country Status (16)

Country Link
US (1) US20090042968A1 (xx)
EP (1) EP1835911B1 (xx)
JP (2) JP4966204B2 (xx)
KR (1) KR20070091682A (xx)
CN (1) CN101083984B (xx)
AR (1) AR052347A1 (xx)
AU (1) AU2005322305B2 (xx)
CA (1) CA2587792C (xx)
CR (1) CR9261A (xx)
IL (1) IL183256A (xx)
MX (1) MX2007007504A (xx)
NO (1) NO20073774L (xx)
NZ (1) NZ555247A (xx)
SG (1) SG161208A1 (xx)
WO (1) WO2006071601A2 (xx)
ZA (2) ZA200704869B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE444732T1 (de) 2003-08-07 2009-10-15 Allergan Inc Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
NZ555247A (en) * 2004-12-23 2010-06-25 Roxro Pharma Inc Therapeutic compositions for intranasal administration of ketorolac
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
JP2011524366A (ja) * 2008-06-13 2011-09-01 ロクスロ・ファーマ・インコーポレイテッド 鼻内投与のためのケトロラクの薬学的処方物
US8277781B2 (en) * 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8551454B2 (en) * 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
CN102614122B (zh) * 2011-01-28 2013-10-16 上海现代药物制剂工程研究中心有限公司 酮咯酸氨丁三醇鼻腔喷雾剂及其制备方法
WO2012127497A1 (en) 2011-03-04 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of ketorolac or salts thereof
MY194947A (en) * 2011-05-13 2022-12-27 Euro Celtique Sa Intranasal pharmaceutical dosage forms comprising naloxone
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
EP3035903B1 (en) 2013-08-20 2018-08-22 Anutra Medical, Inc. Syringe fill system and method
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
CN114191417A (zh) * 2021-12-17 2022-03-18 上海清芮科技有限公司 一种用于宠物的雾化吸入剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4778810A (en) * 1987-01-08 1988-10-18 Nastech Pharmaceutical Co., Inc. Nasal delivery of caffeine
US4943587A (en) * 1988-05-19 1990-07-24 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
US4885287A (en) * 1988-08-09 1989-12-05 University Of Kentucky Research Foundation Novel method of administering aspirin and dosage forms containing same
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
JPH07112984B2 (ja) * 1989-04-28 1995-12-06 久光製薬株式会社 泡状エアゾール製剤
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US6090368A (en) * 1998-03-03 2000-07-18 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
DE10118306A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
NZ555247A (en) * 2004-12-23 2010-06-25 Roxro Pharma Inc Therapeutic compositions for intranasal administration of ketorolac

Also Published As

Publication number Publication date
NO20073774L (no) 2007-09-05
JP2009001586A (ja) 2009-01-08
CN101083984A (zh) 2007-12-05
WO2006071601A2 (en) 2006-07-06
WO2006071601A3 (en) 2006-08-17
JP4966204B2 (ja) 2012-07-04
CA2587792A1 (en) 2006-07-06
AU2005322305B2 (en) 2010-09-16
CN101083984B (zh) 2010-11-10
EP1835911B1 (en) 2012-08-29
MX2007007504A (es) 2007-09-14
US20090042968A1 (en) 2009-02-12
IL183256A (en) 2011-02-28
CA2587792C (en) 2010-07-06
AR052347A1 (es) 2007-03-14
CR9261A (es) 2008-03-18
KR20070091682A (ko) 2007-09-11
ZA200806671B (en) 2009-04-29
EP1835911A2 (en) 2007-09-26
IL183256A0 (en) 2007-10-31
JP2008525455A (ja) 2008-07-17
AU2005322305A1 (en) 2006-07-06
NZ555247A (en) 2010-06-25
SG161208A1 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
IL183256A0 (en) Therapeutic compositions for intranasal administration of ketorolac
IL185018A0 (en) Break-resistant delayed-release forms of administration
SI1802579T1 (sl) Derivati 3-arilaminopiridina
IL212985A0 (en) Therapeutic uses of inhibitors of rtp801
IL177402A0 (en) Composition for oral administration of tamsulosin hydrochloride
HK1119951A1 (en) Methods and compositions for oral administration of proteins
EP1753428A4 (en) INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
ZA200805187B (en) Therapeutic compositions
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
IL186989A0 (en) Therapeutic compositions
EP1951050A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
PL1824450T3 (pl) Kompozycje do podawania donosowego
HK1109332A1 (zh) 藻毒素的經皮給藥
EP2001400A4 (en) ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE
IL197235A0 (en) Therapeutic compositions
EP1740541A4 (en) THERAPEUTIC FORMULATIONS OF DESOXYEPOTHILONES
HK1117420A1 (en) Kit for parenteral administration of medicaments
EP1844792A4 (en) THERAPEUTIC AGENT AGAINST OBSTIPATION
GB0412584D0 (en) Composition of matter
ZA200804266B (en) Therapeutic uses of steroidal compounds
GB0519213D0 (en) Compositions for intranasal administration
EP1809107A4 (en) COMPOSITIONS AND METHODS FOR DELIVERY OF PALLIATIVE OR THERAPEUTIC AGENTS
GB0407731D0 (en) Therapeutic proline derivatives
GB0418363D0 (en) Therapeutic methods and compositions for use therein
GB0407993D0 (en) Therapeutic methods and compositions for use therein